Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis

By Fang Wang, Xiaojiao Liu, Pei Yang, Lingchuan Guo, Chunqi Liu, Hongliang Li, Shuyu Long, Yang-mei Shen, H. Wan. 2014

Citations in the corpus

TROP2 expression in head and neck squamous cell carcinoma: association with the tumor immune microenvironment and clinical outcome (2026, unknown): “…lineage, shaping the tumor microenvironment and differentiation state of tumor cells (33), rather than acting solely as a marker of aggressive tumor biology, while reduced expression has been observed in poorly differentiated squamous cell carcinomas and during tumor progression (12, 34, 35).”